Axpero 1mg Tablet contains Axitinib, which can be taken with or without meals, however for best results, take them at the same time every day. 

Brand Name: Axpero

Composition: Axitinib

Mechanism of Action:

Axitinib selectively inhibits the receptors for vascular endothelial growth factor. By inhibiting VEGF's function, which is essential for tumor growth and metastasis, it impedes angiogenesis, or the development of new blood vessels.

Uses:

Kidney cancer

Side effects: 

•          Fatigue
•          Hot flashes
•          Hypertension
•         Diarrhea
•         Dizziness
•         Nausea
•         Vomiting

Dosage and Administration:

Administered through orally usually once every day. Tablet should be consumed whole, without chewing or opening; they can be taken with or without meals.

Safety Advise:

Liver  

Patients with serious liver disease should use Axpero 1mg tablet with care. It could be necessary to modify the dosage of Axpero 1mg tablet. Kindly speak with your healthcare provider.

Pregnancy  

Using Axpero 1mg tablet while pregnant may be dangerous. Kindly speak with your healthcare provider.

Breast Feeding  

There is no information available on using Axpero 1mg tablet while nursing. Kindly speak with your healthcare provider.

Alcohol  

It is unclear if it is safe to use Axpero 1mg tablet with drinking alcohol. Kindly speak with your healthcare provider.

Storage:

Keep out of children's reach, at room temperature, and away from heat and moisture.

How to use this Medication?

The Axpero 1mg Tablet dosage and duration will be decided by your physician based on your situation. Five mg administered twice a day is the typical first dosage.

Do not chew, crush, or break the pill; instead, drink it whole with water at the same time every day, with or without meals. Do not take two doses to make up for a missed one; instead, take your next scheduled dosage as usual.

References:

1.     Bellesoeur A, Carton E, Alexandre J, Goldwasser F, Huillard O. Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy. Drug design, development and therapy. 2017 Sep 21:2801-11.

2.      Escudier B, Gore M. Axitinib for the management of metastatic renal cell carcinoma. Drugs in R & D. 2011 Jun;11:113-26.

3.      Sonpavde G, Hutson TE, Rini BI. Axitinib for renal cell carcinoma. Expert opinion on investigational drugs. 2008 May 1;17(5):741-8.

4.      Keating GM. Axitinib: a review in advanced renal cell carcinoma. Drugs. 2015 Nov;75:1903-13.

Disclaimer:

The main goal of Apothecare Wellness is to make sure that the information it provides to customers is correct, reliable, and reviewed by specialists. This website's contents and information are strictly for informational purposes. They are not meant to be used in place of expert medical advice, diagnosis, or care. Please consult your physician for guidance and ask any questions you may have about any condition or medication. If you read anything on Apothecare Wellness, do not discount or delay obtaining competent medical advice. Our goal is to enhance the doctor-patient relationship, not to take its place.

Marketer details

Name: Intas Pharmaceuticals Ltd

Address: Chinubhai Centre, Off. Nehru Bridge, Ashram Road, Ahmedabad - 380009. Gujarat. India.

Country of origin: India